CD274 and neoplasm: Wu et al. proposed a high-precision AI system to automatically evaluate the tumor positive cell score (TPS) for NSCLC PD-L1 expression (22C3 and SP263), and the calculated results showed a high degree of agreement between the AI and the pathologist (Wu et al., 2022).